The James Hutton Institute and Blossom Genetics Corporation Limited KTP 21_22 R4
Lead Participant:
THE JAMES HUTTON INSTITUTE
Abstract
To provide pharmaceutical manufacturers with bespoke, consistent raw material to support reduction in costs of cannabis-based drugs, and improve patients' access to treatment.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| THE JAMES HUTTON INSTITUTE | £289,113 | £ 193,706 |
People |
ORCID iD |
| Emma Craig (Project Manager) |